SOLGENT, The Republic of Korea - Komachine Supplier Profile and Product List

- Solgent Co., Ltd. is a specialized molecular diagnostics company established in 2000. The company focuses on the development and production of molecular diagnostic reagents and kits for improving human health and quality of life. Notably, its rapid development and supply of COVID-19 diagnostic kits have earned it significant recognition in the global market. It also provides various research reagents and genome analysis services based on its genomic analysis and molecular diagnostic technologies.Solgent Co., Ltd. is a specialized molecular diagnostics company established in 2000. The company focuses on the development and production of molecular diagnostic reagents and kits for improving human health and quality of life. Notably, its rapid development and supply of COVID-19 diagnostic kits have earned it significant recognition in the global market. It also provides various research reagents and genome analysis services based on its genomic analysis and molecular diagnostic technologies.
- DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit: An in-vitro diagnostic medical device for qualitative detection of SARS-CoV-2 ORF1a and N genes using real-time RT-PCR. This product holds CE-IVD, US FDA Emergency Use Authorization, and MFDS official approval. It represents a rapid and accurate diagnostic system based on OneStep Multiplex RT-qPCR.DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit: An in-vitro diagnostic medical device for qualitative detection of SARS-CoV-2 ORF1a and N genes using real-time RT-PCR. This product holds CE-IVD, US FDA Emergency Use Authorization, and MFDS official approval. It represents a rapid and accurate diagnostic system based on OneStep Multiplex RT-qPCR.
- DiaPlexQ™ ZCD Virus Detection Kit: A research reagent for detecting Zika and Chikungunya viruses. This product is utilized in diagnosing viral infections.DiaPlexQ™ ZCD Virus Detection Kit: A research reagent for detecting Zika and Chikungunya viruses. This product is utilized in diagnosing viral infections.
- DiaPlexC™/DiaPlexQ™ MTC/NTM Detection Kit (Ver.3.0, Ver.4.0): A molecular diagnostic system for the simultaneous detection of Mycobacterium complex and Non-tuberculosis Mycobacteria. This kit plays a crucial role in respiratory disease diagnosis.DiaPlexC™/DiaPlexQ™ MTC/NTM Detection Kit (Ver.3.0, Ver.4.0): A molecular diagnostic system for the simultaneous detection of Mycobacterium complex and Non-tuberculosis Mycobacteria. This kit plays a crucial role in respiratory disease diagnosis.
- Solg™ Taq DNA Polymerase (Amplification) Series: Recombinant thermostable Taq DNA Polymerase highly purified from Thermus aquaticus DNA polymerase gene expressed in E.coli. This is a core enzyme widely used in various PCR applications. It includes 5X Band Doctor™ to address issues of reduced PCR efficiency and non-specific amplification in challenging templates.Solg™ Taq DNA Polymerase (Amplification) Series: Recombinant thermostable Taq DNA Polymerase highly purified from Thermus aquaticus DNA polymerase gene expressed in E.coli. This is a core enzyme widely used in various PCR applications. It includes 5X Band Doctor™ to address issues of reduced PCR efficiency and non-specific amplification in challenging templates.
- Solg™ h-Taq DNA Polymerase (Amplification): A Hot start PCR enzyme with inhibited activity at room temperature, ensuring high specificity. This enzyme is suitable for precise genetic analyses such as SNP and microsatellite analysis. It is recommended for amplifying PCR products less than 1 Kb.Solg™ h-Taq DNA Polymerase (Amplification): A Hot start PCR enzyme with inhibited activity at room temperature, ensuring high specificity. This enzyme is suitable for precise genetic analyses such as SNP and microsatellite analysis. It is recommended for amplifying PCR products less than 1 Kb.
- Solg™ 2X Uh-Taq PCR Series (Amplification): A Hot start PCR product featuring recombinant Taq DNA polymerase treated with specific chemicals. It boasts superior sensitivity, specificity, and amplification efficiency compared to general Taq DNA Polymerase. This product is optimized for low-copy target and multi-target multiplex infection diagnostic experiments.Solg™ 2X Uh-Taq PCR Series (Amplification): A Hot start PCR product featuring recombinant Taq DNA polymerase treated with specific chemicals. It boasts superior sensitivity, specificity, and amplification efficiency compared to general Taq DNA Polymerase. This product is optimized for low-copy target and multi-target multiplex infection diagnostic experiments.
- Genetic Identification Products: Services for identifying rice/brown rice varieties, discriminating Hanwoo/non-Hanwoo cattle, and testing for bovine tuberculosis. The company serves as an accredited inspection agency by the National Agricultural Products Quality Management Service.Genetic Identification Products: Services for identifying rice/brown rice varieties, discriminating Hanwoo/non-Hanwoo cattle, and testing for bovine tuberculosis. The company serves as an accredited inspection agency by the National Agricultural Products Quality Management Service.
- Genome Analysis Services: Provides standard sequencing and primer walking services based on the Sanger method. Offers high-quality, long-read length (700bp) sequence information and customized cause analysis services.Genome Analysis Services: Provides standard sequencing and primer walking services based on the Sanger method. Offers high-quality, long-read length (700bp) sequence information and customized cause analysis services.
- Over 20 years of accumulated technology and know-how in molecular diagnostics and genome analysis. Capabilities for direct development and production of PCR-related enzymes and molecular diagnostic kits.Over 20 years of accumulated technology and know-how in molecular diagnostics and genome analysis. Capabilities for direct development and production of PCR-related enzymes and molecular diagnostic kits.
- Proven ability for rapid development and global supply of diagnostic kits, exemplified by the COVID-19 diagnostic kit. Market leadership and credibility secured through emergency use authorizations from the KCDC and US FDA, and official MFDS approval.Proven ability for rapid development and global supply of diagnostic kits, exemplified by the COVID-19 diagnostic kit. Market leadership and credibility secured through emergency use authorizations from the KCDC and US FDA, and official MFDS approval.
- Establishment of an in-house production system for core raw materials, such as gene amplification enzymes. This contributes to stable product supply and competitive pricing.Establishment of an in-house production system for core raw materials, such as gene amplification enzymes. This contributes to stable product supply and competitive pricing.
- Possession of proprietary gene design technologies, including Allele Specific Multiplex PCR (ASMP). This forms the basis for developing diagnostic products with high sensitivity and specificity.Possession of proprietary gene design technologies, including Allele Specific Multiplex PCR (ASMP). This forms the basis for developing diagnostic products with high sensitivity and specificity.
- A broad product portfolio covering various disease diagnostics and research areas. Offering over 40 types of molecular diagnostic kits and a wide range of research reagents.A broad product portfolio covering various disease diagnostics and research areas. Offering over 40 types of molecular diagnostic kits and a wide range of research reagents.
- Acquisition of international quality and safety certifications such as ISO 9001, ISO 13485, GMP, and CE-IVD. This enhances global market entry and product reliability.Acquisition of international quality and safety certifications such as ISO 9001, ISO 13485, GMP, and CE-IVD. This enhances global market entry and product reliability.
- A global network supplying products and services to over 25 countries, including domestic research institutions, screening centers, medical institutions, and universities. Listed as a strategic stockpile supplier for the US Federal Emergency Management Agency (FEMA).A global network supplying products and services to over 25 countries, including domestic research institutions, screening centers, medical institutions, and universities. Listed as a strategic stockpile supplier for the US Federal Emergency Management Agency (FEMA).
- Molecular Diagnostics Market: Diagnosis of hereditary diseases and infectious diseases (respiratory viruses, tuberculosis, sexually transmitted infections, mosquito-related diseases, etc.).Molecular Diagnostics Market: Diagnosis of hereditary diseases and infectious diseases (respiratory viruses, tuberculosis, sexually transmitted infections, mosquito-related diseases, etc.).
- Basic Science and Clinical Medicine Research: Molecular biology research fields including PCR, cloning, DNA purification, and biochemical reagents.Basic Science and Clinical Medicine Research: Molecular biology research fields including PCR, cloning, DNA purification, and biochemical reagents.
- Genetic Analysis and Identification Services: Human genetic analysis, rice/brown rice variety identification, Hanwoo/non-Hanwoo discrimination, and bovine tuberculosis testing.Genetic Analysis and Identification Services: Human genetic analysis, rice/brown rice variety identification, Hanwoo/non-Hanwoo discrimination, and bovine tuberculosis testing.
- Pharmaceutical and Biotechnology Industry: Supply of molecular diagnostic kits and core raw materials, OEM/ODM partnerships.Pharmaceutical and Biotechnology Industry: Supply of molecular diagnostic kits and core raw materials, OEM/ODM partnerships.
- Public Health and Epidemiology: Establishment of infectious disease diagnosis and prevention systems.Public Health and Epidemiology: Establishment of infectious disease diagnosis and prevention systems.
- China, Vietnam, Thailand, Philippines, KuwaitChina, Vietnam, Thailand, Philippines, Kuwait
- Germany, FranceGermany, France
- Canada, United States (Colorado State Government, FEMA)Canada, United States (Colorado State Government, FEMA)
- ISO 9001:2015 Certification (2018)ISO 9001:2015 Certification (2018)
- ISO 13485:2016 Certification (2018)ISO 13485:2016 Certification (2018)
- GMP Certification (2013, 2016)GMP Certification (2013, 2016)
- CE-IVD Certification (DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Ebola diagnostic products)CE-IVD Certification (DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Ebola diagnostic products)
- U.S. Food and Drug Administration (FDA) Emergency Use Authorization (COVID-19 diagnostic kit)U.S. Food and Drug Administration (FDA) Emergency Use Authorization (COVID-19 diagnostic kit)
- Korean Ministry of Food and Drug Safety (MFDS) Emergency Use Authorization and official approval (COVID-19 diagnostic kit)Korean Ministry of Food and Drug Safety (MFDS) Emergency Use Authorization and official approval (COVID-19 diagnostic kit)
- Venture Company Certification (7th)Venture Company Certification (7th)
- INNO-BIZ Company Selection (7th)INNO-BIZ Company Selection (7th)
- National Agricultural Products Quality Management Service designated rice/brown rice variety inspection agency (No. 30)National Agricultural Products Quality Management Service designated rice/brown rice variety inspection agency (No. 30)
- Possession of 39 patents in total. Key patents include a diagnostic kit for simultaneously detecting Mycobacterium complex and non-tuberculosis mycobacteria (Registration No. 1018658990000), a method and kit for detecting food poisoning bacteria using gene amplification (Registration No. 1018147400000), and a method for concentrating and detecting Norovirus or Hepatitis A virus (Registration No. 1015481670000, exclusive license).Possession of 39 patents in total. Key patents include a diagnostic kit for simultaneously detecting Mycobacterium complex and non-tuberculosis mycobacteria (Registration No. 1018658990000), a method and kit for detecting food poisoning bacteria using gene amplification (Registration No. 1018147400000), and a method for concentrating and detecting Norovirus or Hepatitis A virus (Registration No. 1015481670000, exclusive license).